Total Payments
$19,903
2024 Payments
$1,429
Companies
35
Transactions
351
Medicare Patients
6,571
Medicare Billing
$3.6M
Payment Breakdown by Category
Food & Beverage$9,483 (47.6%)
Gifts$8,780 (44.1%)
Travel$880.73 (4.4%)
Other$750.00 (3.8%)
Education$9.60 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,483 | 343 | 47.6% |
| Gift | $8,780 | 2 | 44.1% |
| Travel and Lodging | $880.73 | 3 | 4.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $750.00 | 2 | 3.8% |
| Education | $9.60 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $11,825 | 68 | $0 (2023) |
| Abbott Laboratories | $977.68 | 9 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $947.13 | 52 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $904.74 | 55 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $754.75 | 35 | $0 (2024) |
| Terumo Medical Corporation | $655.74 | 24 | $0 (2023) |
| Bard Peripheral Vascular, Inc. | $632.39 | 13 | $0 (2024) |
| Edwards Lifesciences Corporation | $484.94 | 3 | $0 (2018) |
| Medtronic Vascular, Inc. | $445.22 | 4 | $0 (2018) |
| Amgen Inc. | $340.80 | 18 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,429 | 65 | Novartis Pharmaceuticals Corporation ($393.82) |
| 2023 | $1,420 | 56 | Bard Peripheral Vascular, Inc. ($397.75) |
| 2022 | $1,608 | 77 | Philips Electronics North America Corporation ($364.99) |
| 2021 | $1,105 | 45 | AstraZeneca Pharmaceuticals LP ($241.38) |
| 2020 | $9,792 | 31 | Philips Electronics North America Corporation ($9,383) |
| 2019 | $2,259 | 46 | Philips Electronics North America Corporation ($1,487) |
| 2018 | $1,212 | 19 | Edwards Lifesciences Corporation ($484.94) |
| 2017 | $1,078 | 12 | Abbott Laboratories ($860.82) |
All Payment Transactions
351 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/09/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: DEVICES | ||||||
| 11/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardiology | ||||||
| 11/02/2024 | Bard Peripheral Vascular, Inc. | LifeStent Solo Vascular Stent (Device) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Vascular/Oncology | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.91 | General |
| 10/18/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.86 | General |
| 10/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/29/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $45.80 | General |
| Category: DEVICES | ||||||
| 09/29/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $45.80 | General |
| Category: DEVICES | ||||||
| 09/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.38 | General |
| 08/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 08/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $40.86 | General |
| Category: Coronary | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,838 | 3,087 | $2.2M | $772,977 |
| 2022 | 30 | 1,644 | 2,889 | $2.5M | $684,279 |
| 2021 | 33 | 1,863 | 3,430 | $4.6M | $1.5M |
| 2020 | 28 | 1,226 | 1,865 | $2.2M | $608,128 |
Total Patients
6,571
Total Services
11,271
Medicare Billing
$3.6M
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 65 | 201 | $643,000 | $239,294 | 37.2% |
| 37229 | Removal of plaque in artery of leg, initial vessel | Office | 2023 | 14 | 20 | $423,000 | $144,177 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 266 | 845 | $230,204 | $65,481 | 28.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 207 | 297 | $131,791 | $52,071 | 39.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 160 | 192 | $103,377 | $41,454 | 40.1% |
| 36466 | Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | Office | 2023 | 12 | 26 | $84,000 | $35,805 | 42.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 129 | 140 | $85,300 | $23,358 | 27.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 220 | 284 | $66,736 | $21,255 | 31.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 65 | 174 | $45,190 | $19,746 | 43.7% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 16 | 22 | $52,100 | $19,391 | 37.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 98 | 105 | $58,800 | $18,471 | 31.4% |
| 37233 | Removal of plaque in artery of leg, each additional vessel | Office | 2023 | 14 | 19 | $57,000 | $18,380 | 32.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 36 | 36 | $40,834 | $13,628 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $45,650 | $12,508 | 27.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 13 | 13 | $15,900 | $9,584 | 60.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 36 | 72 | $18,840 | $6,541 | 34.7% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Office | 2023 | 26 | 34 | $12,050 | $4,007 | 33.3% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 24 | 26 | $8,675 | $3,917 | 45.2% |
| 37253 | Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | Office | 2023 | 16 | 22 | $10,100 | $3,479 | 34.4% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 15 | $34,900 | $3,305 | 9.5% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 11 | 11 | $4,600 | $2,806 | 61.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 152 | 240 | $15,590 | $2,717 | 17.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 16 | 64 | $8,984 | $2,386 | 26.6% |
| 75716 | Review by radiologist of both arms or legs arteries image | Office | 2023 | 15 | 15 | $6,600 | $2,205 | 33.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 36 | 36 | $5,925 | $2,113 | 35.7% |
About Dr. Sachin Kumar Amruthlal Jain, M.D
Dr. Sachin Kumar Amruthlal Jain, M.D is a Cardiovascular Disease healthcare provider based in Yonkers, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134384951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sachin Kumar Amruthlal Jain, M.D has received a total of $19,903 in payments from pharmaceutical and medical device companies, with $1,429 received in 2024. These payments were reported across 351 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,483).
As a Medicare-enrolled provider, Amruthlal Jain has provided services to 6,571 Medicare beneficiaries, totaling 11,271 services with total Medicare billing of $3.6M. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Yonkers, NY
- Active Since 07/21/2008
- Last Updated 10/12/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134384951
Products in Payments
- IGT Devices Und (Device) $9,383
- XARELTO (Drug) $972.52
- Omnilink Elite vascular stent system (Device) $852.83
- Spectranetics Undiv (Device) $750.00
- ENTRESTO (Drug) $642.45
- BRILINTA (Drug) $530.77
- (4066) Tack Endo Sys ATK (Device) $469.98
- ClosureFast (Device) $445.22
- FARXIGA (Drug) $416.36
- MetaCross (Device) $296.32
- IGT_D Peripheral (Device) $273.66
- Repatha (Biological) $265.59
- LEQVIO (Drug) $262.29
- ELIQUIS (Drug) $242.97
- Trilogy 100 (Device) $209.12
- Venovo (Device) $199.00
- Lasers (Device) $181.82
- Crosser iQ (Device) $180.71
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $163.52
- CARDIVA VASCADE 6/7F VCS (Device) $159.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Yonkers
Sang Kim, M.d, M.D
Cardiovascular Disease — Payments: $8,929
Cardiovascular Disease $8,929
Dr. Douglas Hart, Md, MD
Cardiovascular Disease — Payments: $2,441
Cardiovascular Disease $2,441
Slawomir Malendowicz, Md, MD
Cardiovascular Disease — Payments: $2,431
Cardiovascular Disease $2,431
Dr. Gregory Neufeld, M.d, M.D
Cardiovascular Disease — Payments: $2,046
Cardiovascular Disease $2,046
Richard Feldman, M.d, M.D
Cardiovascular Disease — Payments: $1,926
Cardiovascular Disease $1,926
Shahid Sheikh, M.d, M.D
Cardiovascular Disease — Payments: $1,178
Cardiovascular Disease $1,178